ストックスクリーナーアプリを入手
179.01
0.76%
-1.2813
前日終値:
$180.29
開ける：
$181.15
24時間の取引高:
1.47M
Relative Volume:
0.26
時価総額：
$284.35B
収益：
$113.10B
当期純損益:
$16.33B
株価収益率:
18.37
EPS:
9.7425
ネットキャッシュフロー:
$10.35B
1週間 パフォーマンス:
+1.36%
1か月 パフォーマンス:
+5.29%
6か月 パフォーマンス:
+35.62%
1年 パフォーマンス:
+39.88%
1日の値動き範囲:
$178.39
$181.15
1週間の範囲:
$176.06
$181.98
52週間の値動き範囲:
$94.33
$181.98
Morgan Stanley Stock (MS) Company Profile
MS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
178.91 | 286.54B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
896.94 | 273.24B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
95.27 | 172.45B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
119.65 | 110.94B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
384.74 | 31.01B | 14.13B | 1.12B | 45.45M | 14.62 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | 開始されました | BMO Capital Markets | Outperform |
| 2025-07-09 | アップグレード | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-09-11 | ダウングレード | Goldman | Buy → Neutral |
| 2024-08-02 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-01-17 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-01-17 | ダウングレード | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-11-28 | ダウングレード | Societe Generale | Buy → Hold |
| 2023-11-20 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | ダウングレード | Odeon | Buy → Hold |
| 2023-10-20 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | ダウングレード | UBS | Buy → Neutral |
| 2023-09-07 | 開始されました | HSBC Securities | Buy |
| 2023-07-12 | アップグレード | Odeon | Hold → Buy |
| 2023-01-18 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-10 | アップグレード | Odeon | Sell → Hold |
| 2023-01-04 | ダウングレード | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | ダウングレード | Odeon | Hold → Sell |
| 2022-05-03 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-01-28 | ダウングレード | Odeon | Buy → Hold |
| 2021-12-03 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | 繰り返されました | Jefferies | Buy |
| 2021-09-29 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-09-28 | ダウングレード | Berenberg | Buy → Hold |
| 2021-08-13 | ダウングレード | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | 再開されました | Keefe Bruyette | Outperform |
| 2021-06-09 | 開始されました | Jefferies | Buy |
| 2021-04-21 | アップグレード | Berenberg | Hold → Buy |
| 2021-03-02 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | 開始されました | Daiwa Securities | Neutral |
| 2021-01-04 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-11-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-10-13 | 再開されました | JP Morgan | Overweight |
| 2020-07-08 | 開始されました | Seaport Global Securities | Buy |
| 2020-06-24 | アップグレード | DA Davidson | Neutral → Buy |
| 2020-06-23 | 繰り返されました | UBS | Buy |
| 2020-05-21 | アップグレード | Odeon | Hold → Buy |
| 2020-04-14 | アップグレード | Societe Generale | Sell → Buy |
| 2020-03-13 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-04 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-21 | ダウングレード | DA Davidson | Buy → Neutral |
| 2020-02-20 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-01-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | 開始されました | DA Davidson | Buy |
| 2020-01-06 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-29 | ダウングレード | Odeon | Buy → Hold |
| 2019-10-10 | アップグレード | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | アップグレード | Citigroup | Neutral → Buy |
| 2019-04-18 | ダウングレード | Citigroup | Buy → Neutral |
すべてを表示
Morgan Stanley (MS) 最新ニュース
Morgan Stanley highlights four European gambling stocks to own in 2026 - Investing.com UK
Fed Cuts Rate: Will This Accelerate Morgan Stanley's IB Fee Growth? - Zacks Investment Research
Morgan Stanley Adjusts Amgen Price Target to $304 From $329, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Regeneron Pharmaceuticals PT to $768 From $767, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on AbbVie to $269 From $261, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Merck & Co. PT to $102 From $100, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Gilead Sciences to $151 From $147, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Biogen Price Target to $156 From $149, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Bristol-Myers Squibb PT to $37 From $36, Maintains Underweight Rating - marketscreener.com
Morgan Stanley keeps an equal weight rating on KLA Corporation (KLAC) - MSN
Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO) - Yahoo Finance
Morgan Stanley Keeps An Equal Weight Rating On KLA Corporation (KLAC) - Yahoo Finance UK
Got $1,000? 1 Tech Stock to Buy and Hold for Decades. - The Motley Fool
Meta Platforms price target lowered to $750 from $820 at Morgan Stanley - Yahoo Finance
Morgan Stanley price soarsForecast today12-12-2025 - Economies.com
RBC Raises Price Target on Morgan Stanley to $185 From $171, Keeps Sector Perform Rating - marketscreener.com
Coupang stock price target lowered to $31 by Morgan Stanley after data breach - Investing.com
Quantinno Capital Management LP Increases Position in Morgan Stanley $MS - MarketBeat
Planet Labs price target raised to $20 from $4.50 at Morgan Stanley - Investing.com UK
Morgan Stanley Raises Price Target on Ciena to $195 From $185, Keeps Equalweight Rating - marketscreener.com
Morgan Stanley Raises Price Target on Rhythm Pharmaceuticals to $150 From $129, Keeps Overweight Rating - marketscreener.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
Coupang Inc (CPNG) PT Lowered to $31 at Morgan Stanley - StreetInsider
Synopsys stock price target raised to $550 from $510 at Morgan Stanley - Investing.com
Morgan Stanley Adjusts PT on Johnson & Johnson to $197 From $190, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
Morgan Stanley Adjusts Price Target on Pfizer to $28 From $32, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Bank of America to $68 From $70, Maintains Overweight Rating - marketscreener.com
Morgan Stanley's long position in H-shares of Jiangsu Hengrui pharmaceuticals decreases to 2.76% on Dec 8HKEX - marketscreener.com
Canada Pension Plan Investment Board Cuts Holdings in Morgan Stanley $MS - MarketBeat
Morgan Stanley upgrades Lottomatica stock to Overweight on favorable outlook - Investing.com
Bayesian Capital Management LP Acquires New Holdings in Morgan Stanley $MS - MarketBeat
Broadcom stock price target raised to $462 by Morgan Stanley on AI growth - Investing.com
Will Maple Rock’s Exit and Morgan Stanley’s Caution Change Avis Budget Group's (CAR) Narrative? - simplywall.st
Morgan Stanley (MS): Revisiting Valuation After Analyst Upgrades and Growing Options Market Interest - Yahoo Finance
Morgan Stanley expects Macau 4Q GGR to grow 8pct sequentially - GGRAsia
Morgan Stanley: Debt financing on the cards for Genting Singapore with SG$5 billion still to spend on RWS 2.0 expansion - IAG – Inside Asian Gaming
Morgan Stanley Lowers Price Target for Evolution to 750 Kronor (830), Maintains Equal WeightBN - marketscreener.com
Morgan Stanley Stock After Hours (Dec. 11, 2025): MS Holds Near a 52-Week High Ahead of Dec. 12 Open — Fed Liquidity, Rate-Cut Path, and Key Levels to Watch - ts2.tech
Adani Power Gets Yet Another Bullish Call From Morgan Stanley — Check Target Price - NDTV Profit
Morgan Stanley Lowers Comcast (CMCSA) Target Amid Shifts in Wireless and Fiber Outlook - Insider Monkey
Verizon (VZ) edges lower in Morgan Stanley’s target reset amid competitive priorities - MSN
Morgan Stanley Adjusts AT&T (T) Targets in Broader Look at the U.S. Wireless Market - Yahoo Finance
Verizon (VZ) Edges Lower in Morgan Stanley’s Target Reset Amid Competitive Priorities - Yahoo Finance
Does Morgan Stanley’s AI Focus Sharpen ASM International’s (ENXTAM:ASM) Strategic Edge in Chip Equipment? - simplywall.st
Morgan Stanley Maintains Meta Platforms (META) Overweight Recommendation - Nasdaq
Fed’s Next Steps and Markets’ Reactions - Morgan Stanley
Morgan Stanley Buys Lower East Side Medical Condo Unit for $56M - Commercial Observer
Form 424B2 MORGAN STANLEY - StreetInsider
Morgan Stanley (MS) 財務データ
収益
当期純利益
現金流量
EPS
1.29%
大文字化:
|
ボリューム (24 時間):